{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T20:22:47Z","timestamp":1780431767016,"version":"3.54.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We herein report two cases of cathinone intoxication. The first case is about a drug addict who was admitted to the emergency room after the injection of an unknown compound. He presented with tachycardia, palpitations, mydriasis, dyspnea, dizziness, headache and nausea. After leaving the hospital against medical advice, he returned the next day with police escort, presenting aggressiveness and agitation signs. One month later, he returned one more time for sleeping disorders, hallucinations and anxiety. He was finally transferred for his 21st detoxification treatment. The second case concerns a man who was wandering the streets and tried to escape when police officers called him. He confessed to snorting of N-ethylpentedrone and was admitted with severe agitation including delusion of persecution, tachycardia, mydriasis and fever. Because of renal failure, rhabdomyolysis and metabolic acidosis, he was transferred to the intensive care unit where he manifested worsening of the symptoms, turning into coma. He was intubated for 3\u2009days before a complete resolution of the symptoms. A screening was performed by high-resolution mass spectrometry followed by quantifications made by high-performance liquid chromatography coupled with a diode array detector. In the first case, alpha-pyrrolidinohexiophenone was identified only during the first two admissions. However, as plenty of other psychotropic substances were also found, the cathinone alone could not be held directly responsible for the symptoms. In the second case, more than 2,000\u2009ng\/mL of N-ethylpentedrone was found without any decrease in the next 17\u2009h, underlining the long half-life of this compound. Unlike the first case, symptoms could be clearly attributed to the cathinone. In conclusion, cathinones can be found on the Belgian illicit drug market, with various routes of administration and clinical consequences. In these two case reports, some common points were observed initially. However, one patient was finally able to leave the hospital without any treatment, whereas the other would most likely have died without intensive care.<\/jats:p>","DOI":"10.1093\/jat\/bkac092","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:01:00Z","timestamp":1669899660000},"page":"e291-e295","source":"Crossref","is-referenced-by-count":11,"title":["Synthetic Cathinones in Belgium: Two Case Reports with Different Outcomes Observed in the Emergency Room"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1416-6194","authenticated-orcid":false,"given":"M","family":"Deville","sequence":"first","affiliation":[{"name":"Laboratory of Clinical and Forensic Toxicology, CHU Liege , Avenue de l'H\u00f4pital,1, Liege B-4000, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Fedorowicz","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Vivalia, South Luxembourg Clinic , Rue des D\u00e9port\u00e9s 137, Arlon B-6700, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Grandjean","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Biology, South Luxembourg Clinic , Rue des D\u00e9port\u00e9s 137, Arlon B-6700, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Simon","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Vivalia, South Luxembourg Clinic , Rue des D\u00e9port\u00e9s 137, Arlon B-6700, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Charlier","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical and Forensic Toxicology, CHU Liege , Avenue de l'H\u00f4pital,1, Liege B-4000, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"2023012411401814500_R1","article-title":"European drug report 2022: trends and developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2022"},{"key":"2023012411401814500_R2","first-page":"67","article-title":"Behavioural effects of cathinone, an amine obtained from Catha edulis Forsk: comparisons with amphetamine, norpseudoephedrine, apomorphine and nomifensine","volume":"32","author":"Zelger","year":"1980","journal-title":"Bulletin on Narcotics"},{"key":"2023012411401814500_R3","volume-title":"Synthetic cathinones Drug Profile","author":"European Monitoring Centre for Drugs and Drug Addiction"},{"key":"2023012411401814500_R4","first-page":"pp 113","volume-title":"Handbook of Experimental Pharmacology","author":"Baumann","year":"2018"},{"key":"2023012411401814500_R5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00204-013-1163-9","article-title":"Khat and synthetic cathinones: a review","volume":"88","author":"Valente","year":"2014","journal-title":"Archives of Toxicology"},{"key":"2023012411401814500_R6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.forsciint.2013.04.015","article-title":"Designer cathinones\u2013an emerging class of novel recreational drugs","volume":"231","author":"Zawilska","year":"2013","journal-title":"Forensic Science International"},{"key":"2023012411401814500_R7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jemermed.2013.11.104","article-title":"Synthetic cathinones (\u201cbath salts\u201d)","volume":"46","author":"Banks","year":"2014","journal-title":"The Journal of Emergency Medicine"},{"key":"2023012411401814500_R8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2020.173012","article-title":"Synthetic cathinones \u2013 From natural plant stimulant to new drug of abuse","volume":"875","author":"Pieprzycaa","year":"2020","journal-title":"European Journal of Pharmacology"},{"key":"2023012411401814500_R9","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1007\/s00204-021-03083-3","article-title":"An updated review on synthetic cathinones","volume":"95","author":"Soares","year":"2021","journal-title":"Archives of Toxicology"},{"key":"2023012411401814500_R10","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/dta.313","article-title":"Cathinone derivatives: a review of their chemistry, pharmacology and toxicology","volume":"3","author":"Kelly","year":"2011","journal-title":"Drug Testing and Analysis"},{"key":"2023012411401814500_R11","first-page":"pp 333","volume-title":"Novel Psychoactive Substances, Classification, Pharmacology & Toxicology","author":"Layne","year":"2021","edition":"2nd"},{"key":"2023012411401814500_R12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0021-9673(96)00706-6","article-title":"Use of high-performance liquid chromatography with photodiode array UV detection for the creation of a 600-compound library \u2013 Application to forensic toxicology","volume":"763","author":"Gaillard","year":"1997","journal-title":"Journal of Chromatography. A"},{"key":"2023012411401814500_R13","article-title":"Quantitative LC-MS\/MS Combining Confident Identification with Scheduled MRM\u2122, Fast Polarity Switching, UHPLC Time Scales","volume-title":"Technical Note","author":"Taylor","year":"2012"},{"key":"2023012411401814500_R14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/15563650.2018.1502443","article-title":"Fetal death associated with the use of 3,4-MDPHP and \u03b1-PHP","volume":"57","author":"Adamowicz","year":"2019","journal-title":"Clinical Toxicology"},{"key":"2023012411401814500_R15","article-title":"Critical review report: alpha-PHP (\u03b1-pyrrolidinohexanophenone) or PV-7","volume-title":"Forty-second meeting, Geneva","author":"World Health Organization Expert Committee on Drug Dependence"},{"key":"2023012411401814500_R16","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.forsciint.2018.12.001","article-title":"Stability of synthetic cathinones in blood and urine","volume":"295","author":"Adamovicz","year":"2019","journal-title":"Forensic Science International"},{"key":"2023012411401814500_R17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/jat\/bkx071","article-title":"Stability of synthetic cathinones in blood","volume":"41","author":"Glicksberg","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"2023012411401814500_R18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1080\/15563650.2017.1370097","article-title":"Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats","volume":"56","author":"Beck","year":"2018","journal-title":"Clinical Toxicology"},{"key":"2023012411401814500_R19","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3109\/15563650.2011.592838","article-title":"Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)","volume":"49","author":"Derungs","year":"2011","journal-title":"Clinical Toxicology"},{"key":"2023012411401814500_R20","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/jat\/bkx080","article-title":"Toxicokinetics of the synthetic cathinone \u03b1-pyrrolidinohexanophenone","volume":"42","author":"Fujita","year":"2018","journal-title":"Journal of Analytical Toxicology"},{"key":"2023012411401814500_R21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/ams2.182","article-title":"Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinone","volume":"3","author":"Fujita","year":"2016","journal-title":"Acute Medicine & Surgery"},{"key":"2023012411401814500_R22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/jat\/bkab102","article-title":"Toxicological analysis of intoxications with synthetic cathinones","volume":"46","author":"Pieprzyca","year":"2021","journal-title":"Journal of Analytical Toxicology"},{"key":"2023012411401814500_R23","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1080\/15563650.2020.1848100","article-title":"Blood concentrations of synthetic cathinones","volume":"59","author":"Adamovicz","year":"2021","journal-title":"Clinical Toxicology"},{"key":"2023012411401814500_R24","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.ajkd.2011.10.012","article-title":"Recurrent acute kidney injury following bath salts intoxication","volume":"59","author":"Adebamiro","year":"2012","journal-title":"American Journal of Kidney Disease"},{"key":"2023012411401814500_R25","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/j.forsciint.2011.02.026","article-title":"Acute poisoning involving the pyrrolidinophenone-type designer drug 4\u02b9-methylalpha-pyrrolidinohexanophenone (MPHP)","volume":"208","author":"Sauer","year":"2011","journal-title":"Forensic Science International"},{"key":"2023012411401814500_R26","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nrneph.2014.44","article-title":"Nephrotoxic effects of designer drugs: synthetic is not better!","volume":"10","author":"Luciano","year":"2014","journal-title":"Nature Reviews. Nephrology"},{"key":"2023012411401814500_R27","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1177\/0960327121996043","article-title":"Synthetic cathinone poisoning from ingestion of drug-laced \u201cinstant coffee packets\u201d in Taiwan","volume":"40","author":"Chou","year":"2021","journal-title":"Human & Experimental Toxicology"},{"key":"2023012411401814500_R28","doi-asserted-by":"publisher","first-page":"pp 495","DOI":"10.1007\/164_2018_110","volume-title":"New Psychoactive Substances. Handbook of Experimental Pharmacology","author":"Kronstrand","year":"2018"},{"key":"2023012411401814500_R29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.genhosppsych.2012.06.005","article-title":"Excited delirium following use of synthetic cathinones (bath salts)","volume":"34","author":"Penders","year":"2012","journal-title":"General Hospital Psychiatry"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkac092\/48011910\/bkac092.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/46\/9\/e291\/48844507\/bkac092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/46\/9\/e291\/48844507\/bkac092.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T11:42:11Z","timestamp":1674560531000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/46\/9\/e291\/6855747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,12,1]]},"published-print":{"date-parts":[[2023,1,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkac092","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,11,1]]}}}